Axt-Fliedner Roland, Nazar Asia, Bedei Ivonne, Schenk Johanna, Reitz Maleen, Rupp Stefan, Jux Christian, Wolter Aline
Division of Prenatal Medicine, Department of Obstetrics and Gynecology, Justus-Liebig-University, Giessen and University Hospital, Giessen & Marburg, 35392 Giessen, Germany.
Department of Paediatric Cardiology, Children's Hospital, Justus-Liebig-University, Giessen and University Hospital, Giessen & Marburg, 35392 Giessen, Germany.
Diagnostics (Basel). 2024 Jan 23;14(3):238. doi: 10.3390/diagnostics14030238.
We aimed to evaluate retrospectively associated anomalies and outcome in prenatal aortic arch anomalies (AAAs). We included ninety patients with aberrant right subclavian artery (ARSA), right aortic arch (RAA) with mirror image branching (RAA-mirror) or aberrant left subclavian artery (RAA-ALSA) and double aortic arch (DAA) between 2011 and 2020. In total, 19/90 (21.1%) had chromosomal anomalies, the highest rate being within the ARSA subgroup (17/46, 37%). All (13/13) of the RAA-mirror subgroup, 10/27 (37.0%) of RAA-ALSA, 13/46 (28.3%) of ARSA and 0/4 within the DAA subgroup had additional intracardiac anomaly. The rate of extracardiac anomalies was 30.7% in RAA-mirror, 28.3% in ARSA, 25.0% in DAA and 22.2% in the RAA-ALSA subgroup. A total of 42/90 (46.7%) had isolated AAAs: three (7.1%) with chromosomal anomalies, all trisomy 21 (3/26, 11.5%) within the ARSA subgroup. Out of 90, 19 (21.1%) were lost to follow-up (FU). Two (2.2%) intrauterine deaths occurred, and six (6.7%) with chromosomal anomalies terminated their pregnancy. In total, 63 (70.0%) were liveborn, 3/63 (4.8%) with severe comorbidity had compassionate care and 3/60 (5.0%) were lost to FU. The survival rate in the intention-to-treat cohort was 53/57 (93%). Forty-one (77.4%) presented with vascular ring/sling, two (4.9%) with RAA-ALSA developed symptoms and one (2.4%) needed an operation. We conclude that intervention due to vascular ring is rarely necessary. NIPT could be useful in isolated ARSA cases without higher a priori risk for trisomy 21 and after exclusion of other anomalies.
我们旨在回顾性评估产前主动脉弓异常(AAA)的相关异常情况及结局。我们纳入了2011年至2020年间90例患有迷走右锁骨下动脉(ARSA)、镜像分支的右主动脉弓(RAA - mirror)、迷走左锁骨下动脉(RAA - ALSA)或双主动脉弓(DAA)的患者。总体而言,19/90(21.1%)患者存在染色体异常,其中ARSA亚组的发生率最高(17/46,37%)。RAA - mirror亚组的所有患者(13/13)、RAA - ALSA亚组的10/27(37.0%)、ARSA亚组的13/46(28.3%)以及DAA亚组的0/4患者存在额外的心内异常。心外异常发生率在RAA - mirror亚组为30.7%,ARSA亚组为28.3%,DAA亚组为25.0%,RAA - ALSA亚组为22.2%。共有42/90(46.7%)患者为孤立性AAA:3例(7.1%)存在染色体异常,均为21 - 三体(3/26,11.5%),均在ARSA亚组。90例患者中,19例(21.1%)失访。发生2例(2.2%)宫内死亡,6例(6.7%)染色体异常患者终止妊娠。共有63例(70.0%)存活出生,3/63(4.8%)患有严重合并症的患者接受了姑息治疗,3/60(5.0%)失访。意向性治疗队列中的生存率为53/57(93%)。41例(77.4%)表现为血管环/吊带,2例(4.9%)RAA - ALSA患者出现症状,1例(2.4%)需要手术。我们得出结论,因血管环进行干预很少有必要。对于无21 - 三体更高先验风险且排除其他异常的孤立性ARSA病例,无创产前检测(NIPT)可能有用。